Noble Corporation (NYSE:NE) Q4 2023 Earnings Call Transcript February 23, 2024 Noble Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thanks for standing by, and welcome to the Noble Corporation Q4 Earnings Call. I would now like to welcome […]
Mativ Holdings, Inc. (NYSE:MATV) Q4 2023 Earnings Call Transcript February 22, 2024 Mativ Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to Mativ’s Fourth Quarter Full Year 2023 Earnings Conference Call. On the call today from Mativ […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript February 22, 2024 Rhythm Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.7 EPS, expectations were $-0.7. Rhythm Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies […]
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript February 22, 2024 Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […]
MercadoLibre, Inc. (NASDAQ:MELI) Q4 2023 Earnings Call Transcript February 22, 2024 MercadoLibre, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone and welcome to the MercadoLibre’s Earnings Conference Call for the quarter ended December 31, 2023. Thank you […]